LARP7 and atherosclerosis: To explore the therapeutic potential of Larp7 overexpression in treating atherosclerosis, we first generated a tetO‐controlled and Cre‐activated Larp7 gain‐of‐function mouse (named as Larp7tetO, Figure 1A) by using CIRSPR‐Cas9‐mediated homology recombination (HR).